Obesity Connect
Profile Image
  • Saved

I use clinical factors based on the approved indications to minimize coverage hassles. Long-term adherence is generally good if there is good tolerance and efficacy. These are truly miracle drugs for many.

Profile Image
  • Saved

getting coverage is the main challenge in my area, pts are open to start weight loss medications but they cannot afford it and oral medications give only minimal weight loss. many pts do not realize that weight loss medications are frequently taken for life and they nod need to exercise and follow a well balanced diet so they can achieve the best...

Profile Image
  • Saved
case study

Patient Background: A 75-year-old woman presents with progressive weight loss, generalized weakness, easy bruising, and poorly controlled hypertension. On exam, she has thin skin with ecchymoses, proximal muscle weakness, and hypokalemia (serum potassium 2.9 mmol/L).

Family History: The patient reported no family history of hormonal disorders, malignancy, or pituitary pathology relevant to her presentation.

Assessment and Diagnosis: Evaluation revealed elevated 24-hour urinary free cortisol (UFC), elevated morning (8 am) serum cortisol, and non-suppression on a low-dose dexamethasone suppression test (LDDST), with elevated ACTH. Pituitary MRI was negative, and Ga-68 DOTATATE PET/CT showed no ectopic lesion. Bilateral inferior petrosal sinus sampling (BIPSS) with CRH stimulation confirmed MRI-negative, ACTH-dependent Cushing’s disease, although features such as marked weight loss and hypokalemia initially raised suspicion for ectopic ACTH secretion.

Suggested treatment plan: The patient declined surgery and opted for medical therapy with an adrenal steroidogenesis inhibitor plus a dopamine agonist.

Patient education: The patient was educated on the importance of medication adherence and avoidance of drug–drug interactions. She was specifically advised to avoid concurrent use of gastric acid–reducing agents, which can impair treatment absorption and effectiveness.

Follow-up: Medical therapy led to normalization of UFC, improved potassium levels, blood pressure, and glycemic control, along with a 15-lb weight gain. A relapse occurred after initiation of an acid-suppressing medication, which compromised drug absorption. Discontinuation restored efficacy, with rapid normalization of hormone levels and a 50-lb weight gain, improving mobility and strength.

  1. What clinical features in this case suggested ectopic ACTH over typical Cushing’s disease? Answer Severe hypokalemia and marked weight loss suggested ectopic ACTH, unlike the usual weight gain in pituitary Cushing’s disease.
  2. Given the MRI-negative status, what key test confirmed Cushing’s disease and ruled out ectopic ACTH? Answer Bilateral inferior petrosal sinus sampling (BIPSS) showed a post-CRH central-to-peripheral ACTH ratio >3, confirming a pituitary source of ACTH despite negative imaging.
Profile Image
  • Saved
Exercise training modestly improves lipid profiles in dyslipidaemia

Dyslipidaemia is a modifiable risk factor for cardiovascular disease (CVD). A large meta-analysis shows that exercise training (ExTr) yields modest but significant improvements across lipid outcomes.

ExTr reduced total cholesterol (−5.9 mg/dL), LDL (−7.2 mg/dL), triglycerides (−8.0 mg/dL), VLDL (−3.9 mg/dL), and increased HDL (+2.1 mg/dL). Combined aerobic training (AT) and resistance training (RT) produced the most consistent lipid improvements. AT alone improved all five markers, while RT primarily raised HDL.

Meta-regression showed dose–response effects: each additional AT session per week was associated with a reduction in TC of −7.7 mg/dL, and longer sessions (>30 minutes) improved HDL. These findings support tailoring exercise to lipid profiles.

ExTr alone may reduce LDL by ~6.3%, corresponding to a potential 4–5% reduction in ASCVD risk. When combined with pharmacologic therapy, total risk reduction may approach 30%.

However, up to 37% of included studies showed no benefit for certain lipid subtypes, underscoring individual variability. Still, 100% of studies reported benefit for VLDL. Exercise should remain a first-line strategy for dyslipidaemia, with tailored prescriptions using AT and RT. AT should be prioritized in cases of hyperlipidaemia.

How will you incorporate these exercise-specific insights into your dyslipidaemia counselling strategies?

Profile Image
  • Saved
Obesity-Related Glomerulosclerosis-How Adiposity Damages the Kidneys - PubMed

Obesity-Related Glomerulosclerosis-How Adiposity Damages the Kidneys - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/40650024/

Obesity, hypertension, and chronic kidney disease (CKD) constitute the deadly trinity of modern threats for populations of both developed and developing countries. These diseases (together with type 2 diabetes) are...

Obesity, hypertension, and CKD interlink, driving cardiovascular morbidity. Obesity-related glomerulosclerosis arises via inflammatory, compressive, and hemodynamic mechanisms; weight loss, GLP1 agonists, and bariatric surgery offer promising kidney-protective strategies.

Profile Image
  • Saved
Obesity and its management in primary care setting - PubMed

Obesity and its management in primary care setting - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/40305970/

Obesity is a worldwide epidemic affecting adults and children, regardless of their socioeconomic status. Significant progress has been made in understanding the genetic causes contributing to obesity, shedding light on...

Obesity impacts all ages globally, causing serious complications. Prevention, especially in children, and treatment through lifestyle, surgery, and new drugs like GLP-1RAs are crucial, with primary care central.

Profile Image
  • Saved

The GLP-1 agonists work very well. The major problem is Insurance, not covering it to many many people who would benefit from it. It’s heartbreaking to keep this life altering medication from them due to lack of financial resources and lack of insurance coverage.

Profile Image
  • Saved
Severe obesity with hypo-leptinemia - PubMed

Severe obesity with hypo-leptinemia - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/40128964/

Some cases of obesity are thought to be associated with hypo-leptinemia. This may cause decreased appetite suppression resulting in increased appetite, leading to weight gain. Replacement therapy with leptin might...

A case of severe obesity with hypo-leptinemia, absent leptin gene mutations, suggests possible hypothalamic dysfunction and abnormal adipocyte expansion; leptin-replacement therapy may benefit such patients.

Profile Image
  • Saved
The Microbiota and Evolution of Obesity - PubMed

The Microbiota and Evolution of Obesity - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/39673174/

Obesity is a major global concern and is generally attributed to a combination of genetic and environmental factors. Several hypotheses have been proposed to explain the evolutionary origins of obesity...

This review proposes that immune system evolution and pathogen defense (metaflammation), combined with gut microbiota genetics, contribute to obesity's origins, emphasizing a multifactorial, evolutionary and polygenic understanding of the epidemic.

Profile Image
  • Saved
GLP-1 Therapies in Metabolic and Hormonal Health: ENDO 2025 Insights

At ENDO 2025, Dr. Monica Laronda (Lurie Children’s Hospital, Northwestern University) highlighted emerging research investigating how GLP-1 therapies and rising obesity rates may influence puberty onset, menarche timing, and sex-specific disease expression—particularly in adolescents with high BMI or genetic susceptibility. She also discussed environmental and epigenetic drivers of endocrine disruption and underscored the need to consider sex as a biological variable in metabolic research. Dr. Shellsea Portillo (St. Louis University Hospital) presented retrospective data indicating that GLP-1–associated weight loss significantly improved testosterone levels in obese men with type 2 diabetes, suggesting a possible avenue for further exploration as a non-hormonal strategy for managing obesity-related hypogonadism. Together, these insights underscore GLP-1’s emerging but preliminary role in reproductive and metabolic endocrine health.

Profile Image
  • Saved
Obesity, white adipose tissue and cancer - PubMed

Obesity, white adipose tissue and cancer - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/39496581/

White adipose tissue (WAT) is crucial for whole-body energy homeostasis and plays an important role in metabolic and hormonal regulation. While healthy WAT undergoes controlled expansion and contraction to meet...

 

Obesity-induced white adipose tissue dysfunction promotes cancer through systemic inflammation, altered metabolism, and tumor microenvironment remodeling, establishing bidirectional interactions that support tumor growth and reveal potential therapeutic targets.

Profile Image
  • Saved
Background Image DesktopBackground Image Mobile

In a phase 2b study, efruxifermin added to stable GLP-1RA therapy in MASH patients with T2D was safe and reduced hepatic fat fraction by 65% vs. 10% with GLP-1RA alone. It also improved noninvasive fibrosis and metabolic markers without impacting weight loss benefits.

Review the full trial findings here

Profile Image
  • Saved

Did you know? Statins are linked to a 9–12% increased risk of new-onset diabetes, particularly with long-term, high-dose use and in patients with impaired glucose regulation. Still, their cardiovascular benefits usually outweigh this risk, prompting continued use in most at-risk populations.

Could statins’ effects on insulin release and sensitivity explain their role in glucose abnormalities?

Statins

Could statins’ effects on insulin release and sensitivity explain their role in glucose abnormalities?

Profile Image
  • Saved
Profile Image
  • Saved
Post metabolic bariatric surgery weight regain: the importance of GLP-1 levels - PubMed

Post metabolic bariatric surgery weight regain: the importance of GLP-1 levels - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38225284/

Weight regain and insufficient weight loss are essential problems after metabolic bariatric surgery (MBS) in people living with obesity. Changes in the level of glucagon-like peptide-1 (GLP-1) secreted from the...

 

This review highlights post-bariatric surgery GLP-1 changes linked to weight loss success and suggests GLP-1 receptor agonists as promising treatments for weight regain or insufficient weight loss after surgery.

Profile Image
  • Saved
ADA 2025 Highlights: Obesity Therapies, Islet Cell Advances, and Oral GLP-1 Outcomes in T2D

At ADA 2025, Dr. Mark Atkinson (University of Florida Diabetes Institute) highlighted the systemic benefits of obesity-targeted therapies, including cardiometabolic and cognitive improvements, while noting concerns about implementation and potential muscle loss. Emerging advances in stem cell–derived islet transplantation for type 1 diabetes show promise in reducing insulin dependence. Dr. John Buse (University of North Carolina) presented SOUL trial data indicating that oral GLP-1 receptor agonist therapy reduced major adverse cardiovascular events—CV death, nonfatal MI, or stroke—by 14%, with additional reductions in limb complications in high-risk patients with type 2 diabetes.

Profile Image
  • Saved
Enhancing gut microbiota and microbial function with inulin supplementation in children with obesity - PubMed

Enhancing gut microbiota and microbial function with inulin supplementation in children with obesity - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/39033197/

Inulin supplementation significantly promoted gut bacterial diversity and improved gut microbiota dysbiosis in children with obesity. The modulation of functional pathways by inulin suggests its potential to establish beneficial interactions...

 

Inulin supplementation in children with obesity improved gut microbiota diversity, increased beneficial bacterial populations, and modulated functional pathways, suggesting its potential as a therapeutic strategy for microbiota restoration and metabolic improvement.

Profile Image
  • Saved
Obesity pharmacotherapy in older adults: a narrative review of evidence - PubMed

Obesity pharmacotherapy in older adults: a narrative review of evidence - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38710803/

The prevalence of obesity in older adults (people aged >60 years) is increasing in line with the demographic shift in global populations. Despite knowledge of obesity-related complications in younger adults...

 

Obesity in older adults poses unique risks, but intentional weight loss—via lifestyle changes and emerging anti-obesity medications—can be safe and effective, improving health while preserving muscle and functional ability.

Profile Image
  • Saved
Approach to Obesity Treatment in Primary Care: A Review - PubMed

Approach to Obesity Treatment in Primary Care: A Review - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38466272/

Primary care clinicians play a vital role in the assessment, management, and support of patients with obesity. With careful clinical assessment and shared decision-making, a flexible treatment plan can be...

 

Effective obesity care in primary settings requires integrating lifestyle changes with adjunctive therapies like antiobesity medications or surgery, enabling sustained weight loss and health gains through individualized, evidence-based treatment plans.

Profile Image
  • Saved
Exercise as a Therapeutic Strategy for Obesity: Central and Peripheral Mechanisms - PubMed

Exercise as a Therapeutic Strategy for Obesity: Central and Peripheral Mechanisms - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/39590824/

Obesity is a complex, multifactorial condition involving excessive fat accumulation due to an imbalance between energy intake and expenditure, with its global prevalence steadily rising. This condition significantly increases the...

 

Exercise combats obesity by modulating central nervous system functions and enhancing peripheral metabolic processes, promoting fat oxidation and energy balance; deeper insight into these interactions can improve obesity management strategies.

Profile Image